Ebola Updates Could Spark Hemispherx Biopharma (HEB) Stock

HEBWith ebola now having been diagnosed within the continental U.S., investors have been scrambling to find stocks that focus on finding some form of cure or treatment against the deadly disease. One NYSE-Amex listed penny stock, Hemispherx Biopharma, Inc. (HEB), has seen a flurry of traders flocking towards the specialty biopharmaceutical firm in hopes of being able to catch a ride on the hype-train for a chance to ...

Continue Reading →
0